Bladder cancer
Select a topic to solve related cases or follow a course topic
-
Topic 1Initial treatment of MIBC
-
Topic 2Management of BCG-pretreated (very) high-risk NMIBC
-
Topic 3Treatment approaches for patients diagnosed with (very) high-risk NMIBC
-
Topic 4Targeted therapies for metastatic UCa in special populations
-
Topic 5First-line therapy of synchronous and metachronous metastatic UCa
-
Topic 6New hope for patients progressing after prior treatment for mUCa
-
Topic 7Handling AEs of targeted therapies for metastatic UCa
-
Topic 8Molecular diagnostics in the era of targeted therapies for mUCa
-
Topic 9Adjuvant treatment approaches for MIBC
-
Topic 10Histological subtypes of (N)MIBC: managed differently compared to pure UCa?
-
Topic 11Follow-up surveillance regimes to consider for (very) high-risk NMIBC and MIBC
-
Topic 12Follow-up surveillance regimes for low-/intermediate-risk NMIBC
-
Topic 13Low- and intermediate-risk NMIBC: surveillance or intravesical therapy?
Meet our multidisciplinary team of contributing experts
Editor in chief
Maria De Santis
Go to our other case-based CME offerings:
Do the 5-minute QuickScan to test if you're up to date and complete your personalised case journey. Available for various disease areas and specialties.
Take a minute to solve your regularly case challenge. Subscribe for free to receive them in your mailbox.